A Food and Drug Administration voted against recommending the approval of extra doses of the Covid-19 vaccine for most people in the U.S., but a second vote on a narrower recommendation could follow.
The outside panel on Friday voted 16-2 against advising the FDA to approve a booster dose of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE at least six months after the second shot for people 16 years and older.
